Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nevro bucks trend with upsized IPO

This article was originally published in Clinica

Executive Summary

Nevro has upsized its initial public offering, raising $126m from the sale of seven million shares at $18 each. The firm, which has a CE-marked spinal cord stimulation system for managing chronic pain, will begin trading on the New York Stock Exchange today, under the ticker symbol NVRO. The offering is expected to close 12 November.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT102082

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel